Literature DB >> 22517901

Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency.

Tomoki Kawai1, Ryuta Nishikomori, Kazushi Izawa, Yuuki Murata, Naoko Tanaka, Hidemasa Sakai, Megumu Saito, Takahiro Yasumi, Yuki Takaoka, Tatsutoshi Nakahata, Tomoyuki Mizukami, Hiroyuki Nunoi, Yuki Kiyohara, Atsushi Yoden, Takuji Murata, Shinya Sasaki, Etsuro Ito, Hiroshi Akutagawa, Toshinao Kawai, Chihaya Imai, Satoshi Okada, Masao Kobayashi, Toshio Heike.   

Abstract

Somatic mosaicism has been described in several primary immunodeficiency diseases and causes modified phenotypes in affected patients. X-linked anhidrotic ectodermal dysplasia with immunodeficiency (XL-EDA-ID) is caused by hypomorphic mutations in the NF-κB essential modulator (NEMO) gene and manifests clinically in various ways. We have previously reported a case of XL-EDA-ID with somatic mosaicism caused by a duplication mutation of the NEMO gene, but the frequency of somatic mosaicism of NEMO and its clinical impact on XL-EDA-ID is not fully understood. In this study, somatic mosaicism of NEMO was evaluated in XL-EDA-ID patients in Japan. Cells expressing wild-type NEMO, most of which were derived from the T-cell lineage, were detected in 9 of 10 XL-EDA-ID patients. These data indicate that the frequency of somatic mosaicism of NEMO is high in XL-ED-ID patients and that the presence of somatic mosaicism of NEMO could have an impact on the diagnosis and treatment of XL-ED-ID patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517901     DOI: 10.1182/blood-2011-05-354167

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Successful hematopoietic cell transplantation in patients with unique NF-κB essential modulator (NEMO) mutations.

Authors:  J K Abbott; R R Quinones; M T de la Morena; E W Gelfand
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

2.  Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.

Authors:  Hidenori Ohnishi; Yuka Kishimoto; Tomohide Taguchi; Norio Kawamoto; Mina Nakama; Tomoki Kawai; Manabu Nakayama; Osamu Ohara; Kenji Orii; Toshiyuki Fukao
Journal:  J Clin Immunol       Date:  2017-07-12       Impact factor: 8.317

3.  Time Course of Conical Teeth in Anhidrotic Ectodermal Dysplasia with Immunodeficiency.

Authors:  Yuta Aizawa; Chihaya Imai; Akihiko Saitoh
Journal:  J Clin Immunol       Date:  2022-06-09       Impact factor: 8.542

4.  Autosomal dominant anhidrotic ectodermal dysplasia with immunodeficiency caused by a novel NFKBIA mutation, p.Ser36Tyr, presents with mild ectodermal dysplasia and non-infectious systemic inflammation.

Authors:  Takakazu Yoshioka; Ryuta Nishikomori; Junichi Hara; Keiko Okada; Yoshiko Hashii; Ikuo Okafuji; Seishiro Nodomi; Tomoki Kawai; Kazushi Izawa; Hidenori Ohnishi; Takahiro Yasumi; Tatsutoshi Nakahata; Toshio Heike
Journal:  J Clin Immunol       Date:  2013-07-18       Impact factor: 8.317

5.  T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency.

Authors:  Stephanie Heller; Uwe Kölsch; Thomas Magg; Renate Krüger; Andrea Scheuern; Holm Schneider; Anna Eichinger; Volker Wahn; Nadine Unterwalder; Myriam Lorenz; Klaus Schwarz; Christian Meisel; Ansgar Schulz; Fabian Hauck; Horst von Bernuth
Journal:  J Clin Immunol       Date:  2020-01-21       Impact factor: 8.317

Review 6.  ICON: the early diagnosis of congenital immunodeficiencies.

Authors:  John Routes; Mario Abinun; Waleed Al-Herz; Jacinta Bustamante; Antonio Condino-Neto; Maria Teresa De La Morena; Amos Etzioni; Eleonora Gambineri; Elie Haddad; Lisa Kobrynski; Francoise Le Deist; Shigeaki Nonoyama; Joao Bosco Oliveira; Elena Perez; Capucine Picard; Nima Rezaei; John Sleasman; Kathleen E Sullivan; Troy Torgerson
Journal:  J Clin Immunol       Date:  2014-03-12       Impact factor: 8.542

7.  Simulation of the dynamics of primary immunodeficiencies in CD4+ T-cells.

Authors:  Gabriel N Teku; Mauno Vihinen
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

8.  CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein.

Authors:  Milad Babaei; Yuekun Liu; Shelly M Wuerzberger-Davis; Ethan Z McCaslin; Christopher J DiRusso; Alan T Yeo; Larisa Kagermazova; Shigeki Miyamoto; Thomas D Gilmore
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

9.  Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.

Authors:  Charline Miot; Kohsuke Imai; Chihaya Imai; Anthony J Mancini; Zeynep Yesim Kucuk; Tokomki Kawai; Ryuta Nishikomori; Etsuro Ito; Isabelle Pellier; Sophie Dupuis Girod; Jeremie Rosain; Shinya Sasaki; Shanmuganathan Chandrakasan; Jana Pachlopnik Schmid; Tsubasa Okano; Estelle Colin; Alberto Olaya-Vargas; Marco Yamazaki-Nakashimada; Waseem Qasim; Sara Espinosa Padilla; Andrea Jones; Alfons Krol; Nyree Cole; Stephen Jolles; Jack Bleesing; Thomas Vraetz; Andrew R Gennery; Mario Abinun; Tayfun Güngör; Beatriz Costa-Carvalho; Antonio Condino-Neto; Paul Veys; Steven M Holland; Gulbu Uzel; Despina Moshous; Benedicte Neven; Stéphane Blanche; Stephan Ehl; Rainer Döffinger; Smita Y Patel; Anne Puel; Jacinta Bustamante; Erwin W Gelfand; Jean-Laurent Casanova; Jordan S Orange; Capucine Picard
Journal:  Blood       Date:  2017-07-05       Impact factor: 22.113

10.  Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency.

Authors:  Christian Klemann; Ulrich Pannicke; Deborah J Morris-Rosendahl; Katerina Vlantis; Marta Rizzi; Holm Uhlig; Thomas Vraetz; Carsten Speckmann; Brigitte Strahm; Manolis Pasparakis; Klaus Schwarz; Stephan Ehl; Jan C Rohr
Journal:  Clin Immunol       Date:  2016-01-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.